Follow
Direct Oral Anticoagulants (DOACs)
Direct oral anticoagulants (DOACs) is the generic term for a group of anticoagulating substances that act directly against certain coagulation factors and can be taken orally (or by mouth). Traditional anticoagulants such as warfarin, coumarin and heparin are in widespread use.
APR 22, 2020 | 8:00 AM
Rapid access to high quality comprehensive coagulation test results is critical to patient care. In an environment where clinical laboratories constantly experience price and labor pressure,...
APR 20, 2020 | 8:00 AM
This talk will cover different approaches to emergency hemostasis testing for patients that are actively bleeding due to trauma, surgery, obstetrical emergencies and other causes. The talk i...
FEB 05, 2020 | 8:00 AM
The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of inter...
APR 22, 2019 | 12:00 AM
ABSTRACT Learning objectives: Highlight recent clinical trials describing use of DOACs Demonstrate if (ever) one needs to monitor DOACS Review best practice with respec...
NOV 08, 2017 | 6:00 AM
Monitoring unfractionated heparin (UFH) using the activated partial thromboplastin time (APTT) or the anti-factor Xa (anti-Xa) chromogenic assay still seems to be a controversy. Is the...
APR 26, 2017 | 6:00 AM
When patients taking direct oral anticoagulants (DOAC's) are admitted to the hospital, there may be a need for bridging parental anticoagulation especially for those at high risk of throm...
FEB 05, 2020 | 8:00 AM
The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of inter...
APR 22, 2019 | 12:00 AM
ABSTRACT Learning objectives: Highlight recent clinical trials describing use of DOACs Demonstrate if (ever) one needs to monitor DOACS Review best practice with respec...
NOV 08, 2017 | 6:00 AM
Monitoring unfractionated heparin (UFH) using the activated partial thromboplastin time (APTT) or the anti-factor Xa (anti-Xa) chromogenic assay still seems to be a controversy. Is the...